Topical antiglaucoma drugs | With VF deterioration | Without VF deterioration | p Value at 95% CI |
---|---|---|---|
χ2 test. | |||
VF, visual field; CI, confidence interval. | |||
Beta blockers | 75.0% | 64.6% | 0.35 |
Carbonic anhydrase inhibitors | 67.8% | 45.8% | 0.06 |
Alpha agonists | 28.6% | 16.7% | 0.2 |